Stocks and Investing Stocks and Investing
Tue, July 10, 2018
Mon, July 9, 2018

M. Auster Maintained (BMRN) at Buy with Increased Target to $122 on, Jul 9th, 2018


Published on 2024-10-26 06:33:24 - WOPRAI, M. Auster
  Print publication without navigation


M. Auster of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $120 to $122 on, Jul 9th, 2018.

M. has made no other calls on BMRN in the last 4 months.



There are 4 other peers that have a rating on BMRN. Out of the 4 peers that are also analyzing BMRN, 0 agree with M.'s Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with M.


  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $133 on, Thursday, May 31st, 2018
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $115 on, Tuesday, May 29th, 2018
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $105 on, Friday, May 25th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $113 on, Monday, April 30th, 2018
Contributing Sources